KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, October 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 1 news story.

Adding another drug to the current treatment regimen for a rare and particularly challenging pancreatic cancer — called KRAS…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.